BioLineRx Ltd. Gains Losses On Change In Fair Value Of Derivatives
BioLineRx Ltd. (BLRX) reported Gains Losses On Change In Fair Value Of Derivatives of $454.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Income Statement › Other Income
ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives · last filed 2026-03-23
| Period end | Gains Losses On Change In Fair Value Of Derivatives 6 month | Gains Losses On Change In Fair Value Of Derivatives 12 month | Gains Losses On Change In Fair Value Of Derivatives 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $454.00K 20-F · filed 2026-03-23 | ||
| 2024-12-31 | $11.43M 20-F · filed 2026-03-23 | $11.03M 20-F · filed 2025-03-31 | |
| 2023-12-31 | $11.43M 20-F · filed 2025-03-31 | $4.57M 20-F · filed 2024-03-26 | |
| 2023-06-30 | $10.84M 6-K · filed 2023-08-30 | ||
| 2022-12-31 | $11.03M 20-F · filed 2024-03-26 | $4.57M 20-F · filed 2023-03-22 | |
| 2016-12-31 | $110.00K 20-F · filed 2018-03-06 | ||
| 2015-12-31 | $700.00K 20-F · filed 2018-03-06 |